Your browser doesn't support javascript.
loading
Obesity, cancer, and response to immune checkpoint inhibitors: Could the gut microbiota be the mechanistic link?
Delaye, Matthieu; Rousseau, Adrien; Mailly-Giacchetti, Léah; Assoun, Sandra; Sokol, Harry; Neuzillet, Cindy.
Afiliación
  • Delaye M; Curie Institute, Department of medical oncology, Versailles Saint-Quentin University, Saint-Cloud, France; GERCOR, 75011 Paris, France.
  • Rousseau A; Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France.
  • Mailly-Giacchetti L; Department of Medical Oncology, Saint-Louis Hospital, AP-HP.Nord - Université de Paris, Paris, France.
  • Assoun S; Department of Thoracic Oncology & CIC 1425/CLIP2 Paris-Nord, Bichat-Claude Bernard Hospital, APHP, Paris, France.
  • Sokol H; Paris Center for Microbiome Medicine (PaCeMM) FHU, Paris, France; Sorbonne Université, INSERM UMRS-938, Centre de Recherche Saint-Antoine, CRSA, AP-HP, Paris, France; INRAE, AgroParisTech, Micalis Institut, 78350, Jouy-en-Josas, France.
  • Neuzillet C; Curie Institute, Department of medical oncology, Versailles Saint-Quentin University, Saint-Cloud, France; GERCOR, 75011 Paris, France. Electronic address: cindy.neuzillet@curie.fr.
Pharmacol Ther ; 247: 108442, 2023 Jul.
Article en En | MEDLINE | ID: mdl-37210004
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Microbioma Gastrointestinal / Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Pharmacol Ther Año: 2023 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Microbioma Gastrointestinal / Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Pharmacol Ther Año: 2023 Tipo del documento: Article País de afiliación: Francia